ophthalmologytimes14h
Promising non-surgical treatment for early cataracts: Insights from a Phase II clinical trial
Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...
World’s first stem-cell treatment restores vision for patients with severe corneal damage
Japanese scientists conducted a clinical trial using stem cells to treat severe corneal damage. The trial involved four ...
The Indian Express4d
Understanding temporary vision loss: Causes and treatment options
Sharp object trauma might jeopardise ocular integrity, whilst blunt force strikes can cause elevated pressure, perhaps ...
India Today on MSN5d
World's first stem cell treatment restores vision, offers new hope to the blind
A Lancet study has highlighted lasting vision improvements in four patients with damaged corneas using reprogrammed stem-cell ...